Bausch Health Companies BHC
NYSE BHC
$6.44 -0.37 (-5.43%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012)

Bausch Health Companies (BHC) posted Long-Term Investments of $7.2 million for Q4 2012, down 21.84% sequentially from $9.2 million in Q2 2011.

Bausch Health Companies (BHC) Long-Term Investments (2009 - 2012) Analysis & Trends

Bausch Health Companies has reported Long-Term Investments for 4 years, with the latest figure at $7.2 million in Q4 2012.

  • Quarterly Long-Term Investments changed N/A year-over-year to $7.2 million in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $7.2 million (changed N/A YoY) and the FY2012 annual result came in at $7.2 million, changed N/A from the prior year.
  • Long-Term Investments fell to $7.2 million in Q4 2012 per BHC's latest filing, from $9.2 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $80.0 million in Q1 2011 and troughed at $2.1 million in Q4 2010.
  • A 4-year average of $17.6 million and a median of $9.2 million in 2011 frame the typical range for Long-Term Investments.
  • The sharpest annual moves came in 2010 and 2011: Long-Term Investments slumped 81.91% in 2010, then retreated 5.07% in 2011.
  • Over 4 years, Long-Term Investments stood at $11.5 million in 2009, then plunged by 81.91% to $2.1 million in 2010, then surged by 340.23% to $9.2 million in 2011, then slipped by 21.84% to $7.2 million in 2012.
  • According to Business Quant data, Long-Term Investments over the past three periods registered $7.2 million, $9.2 million, and $80.0 million for Q4 2012, Q2 2011, and Q1 2011 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 92.58 Mn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 63.23 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 1.14 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 149.10 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 60.00 Mn
10 Bausch Health Companies 2.42 Bn 586.38 Mn 2.10 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2012 7.17 Mn
Jun 30, 2011 9.17 Mn
Mar 31, 2011 79.95 Mn
Dec 31, 2010 2.08 Mn
Sep 30, 2010 3.65 Mn
Jun 30, 2010 9.66 Mn
Dec 31, 2009 11.52 Mn